234 related articles for article (PubMed ID: 12062643)
1. Chromatographic determination of the association constants between nimesulide and native and modified beta-cyclodextrins.
Ravelet C; Geze A; Villet A; Grosset C; Ravel A; Wouessidjewe D; Peyrin E
J Pharm Biomed Anal; 2002 Jul; 29(3):425-30. PubMed ID: 12062643
[TBL] [Abstract][Full Text] [Related]
2. Effect of pH and water-soluble polymers on the aqueous solubility of nimesulide in the absence and presence of beta-cyclodextrin derivatives.
Alexanian C; Papademou H; Vertzoni M; Archontaki H; Valsami G
J Pharm Pharmacol; 2008 Nov; 60(11):1433-9. PubMed ID: 18957163
[TBL] [Abstract][Full Text] [Related]
3. Study on the inclusion complexes of bromazepam with beta- and beta-hydroxypropyl-cyclodextrins.
Archontaki HA; Vertzoni MV; Athanassiou-Malaki MH
J Pharm Biomed Anal; 2002 May; 28(3-4):761-9. PubMed ID: 12008156
[TBL] [Abstract][Full Text] [Related]
4. HPLC determination of sertraline in bulk drug, tablets and capsules using hydroxypropyl-beta-cyclodextrin as mobile phase additive.
Chen D; Jiang S; Chen Y; Hu Y
J Pharm Biomed Anal; 2004 Jan; 34(1):239-45. PubMed ID: 14738940
[TBL] [Abstract][Full Text] [Related]
5. Role of the Na+ ion on phenol derivatives/hydroxypropyl-beta-cyclodextrin complex formation on porous graphitic carbon phase.
Guillaume YC; Truong TT; Millet J; Nicod L; Rouland JC; Thomassin M
J Chromatogr A; 2002 May; 955(2):197-205. PubMed ID: 12075923
[TBL] [Abstract][Full Text] [Related]
6. Comparative study on the inclusion behaviour of cyclodextrin derivatives with venoruton and rutin by thin layer chromatography.
Guo X; Shuang S; Wang X; Dong C; Pan J; Aboul-Enein HY
Biomed Chromatogr; 2004 Oct; 18(8):559-63. PubMed ID: 15386516
[TBL] [Abstract][Full Text] [Related]
7. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
[TBL] [Abstract][Full Text] [Related]
8. Study of the interaction between S(--) bupivacaine and 2-hydroxypropyl-beta-cyclodextrin.
Moraes CM; Abrami P; de Paula E; Braga AF; Fraceto LF
Int J Pharm; 2007 Feb; 331(1):99-106. PubMed ID: 17071028
[TBL] [Abstract][Full Text] [Related]
9. Study on the inclusion complexes of cryptotanshinone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Li JF; Wei YX; Ding LH; Dong C
Spectrochim Acta A Mol Biomol Spectrosc; 2003 Oct; 59(12):2759-66. PubMed ID: 14499836
[TBL] [Abstract][Full Text] [Related]
10. HPLC determination of ketoprofen enantiomers in human serum using a nonporous octadecylsilane 1.5 microns column with hydroxypropyl beta-cyclodextrin as mobile phase additive.
Ameyibor E; Stewart JT
J Pharm Biomed Anal; 1998 May; 17(1):83-8. PubMed ID: 9608430
[TBL] [Abstract][Full Text] [Related]
11. HPLC and solubility study of the interaction between pindolol and cyclodextrins.
Gazpio C; Sánchez M; García-Zubiri IX; Vélaz I; Martínez-Ohárriz C; Martín C; Zornoza A
J Pharm Biomed Anal; 2005 Mar; 37(3):487-92. PubMed ID: 15740908
[TBL] [Abstract][Full Text] [Related]
12. Investigation of curcumin-cyclodextrin inclusion complexation in aqueous solutions containing various alcoholic co-solvents and alginates using an UV-VIS titration method. Studies of curcumin and curcuminoides, XXXV.
Hegge AB; Másson M; Kristensen S; Tønnesen HH
Pharmazie; 2009 Jun; 64(6):382-9. PubMed ID: 19618675
[TBL] [Abstract][Full Text] [Related]
13. Liquid chromatographic study of two structural isomeric pentacyclic triterpenes on reversed-phase stationary phase with hydroxypropyl-β-cyclodextrin as mobile phase additive.
Bao H; Sun W; Sun H; Jin Y; Gong X; Chu C; Tong S
J Pharm Biomed Anal; 2022 Jan; 207():114420. PubMed ID: 34662781
[TBL] [Abstract][Full Text] [Related]
14. Effect of hydroxypropyl-beta-cyclodextrin on the solubility of an antibacterial isoxazolyl-naphthoquinone.
Linares MS; de Bertorello MM; Longhi MR
Drug Dev Ind Pharm; 2000 Sep; 26(9):1003-6. PubMed ID: 10914326
[TBL] [Abstract][Full Text] [Related]
15. Interaction between nitroheterocyclic compounds with beta-cyclodextrins: phase solubility and HPLC studies.
de Melo NF; Grillo R; Rosa AH; Fraceto LF
J Pharm Biomed Anal; 2008 Aug; 47(4-5):865-9. PubMed ID: 18534804
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the complexation of diflunisal with hydroxypropyl-beta-cyclodextrin.
Ugwu SO; Alcala MJ; Bhardwaj R; Blanchard J
J Pharm Biomed Anal; 1999 Mar; 19(3-4):391-7. PubMed ID: 10704104
[TBL] [Abstract][Full Text] [Related]
17. Solubility, Permeability, Anti-Inflammatory Action and In Vivo Pharmacokinetic Properties of Several Mechanochemically Obtained Pharmaceutical Solid Dispersions of Nimesulide.
Wei W; Evseenko VI; Khvostov MV; Borisov SA; Tolstikova TG; Polyakov NE; Dushkin AV; Xu W; Min L; Su W
Molecules; 2021 Mar; 26(6):. PubMed ID: 33802031
[TBL] [Abstract][Full Text] [Related]
18. Solubilization of Fluasterone in cosolvent/cyclodextrin combinations.
He Y; Li P; Yalkowsky SH
Int J Pharm; 2003 Oct; 264(1-2):25-34. PubMed ID: 12972333
[TBL] [Abstract][Full Text] [Related]
19. Bupivacaine hydrochloride complexation with some alpha- and beta-cyclodextrins studied by potentiometry with membrane electrodes.
Kopecký F; Vojteková M; Kaclík P; Demko M; Bieliková Z
J Pharm Pharmacol; 2004 May; 56(5):581-7. PubMed ID: 15142334
[TBL] [Abstract][Full Text] [Related]
20. Chromatographic determination of the association constant between 8-methoxypsoralen and modified beta-cyclodextrin: protective effect of hydroxypropyl-beta-cyclodextrin on 8-methoxypsoralen toxicity in human keratinocytes.
Guillaume Y; Andre C; Simon N; Gehin A; Guyon C; Thomassin M; Ismaili L; Aubin F; Nicod L
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Dec; 798(2):217-22. PubMed ID: 14643500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
